Parametric Portfolio Associates LLC Has $18.39 Million Holdings in Ambev S.A. (ABEV)
Parametric Portfolio Associates LLC trimmed its position in shares of Ambev S.A. (NYSE:ABEV) by 12.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,350,291 shares of the company’s stock after selling 488,219 shares during the quarter. Parametric Portfolio Associates LLC’s holdings in Ambev were worth $18,393,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Harding Loevner LP boosted its holdings in shares of Ambev by 1.8% in the 2nd quarter. Harding Loevner LP now owns 24,323,634 shares of the company’s stock worth $133,537,000 after buying an additional 420,020 shares during the last quarter. Suntrust Banks Inc. boosted its holdings in shares of Ambev by 88.2% in the 2nd quarter. Suntrust Banks Inc. now owns 358,346 shares of the company’s stock worth $1,966,000 after buying an additional 167,985 shares during the last quarter. Bluestein R H & Co. boosted its holdings in shares of Ambev by 42.9% in the 2nd quarter. Bluestein R H & Co. now owns 100,000 shares of the company’s stock worth $549,000 after buying an additional 30,000 shares during the last quarter. Quantbot Technologies LP purchased a new position in shares of Ambev in the 2nd quarter worth about $308,000. Finally, FIL Ltd boosted its holdings in shares of Ambev by 6.1% in the 2nd quarter. FIL Ltd now owns 10,473,468 shares of the company’s stock worth $57,499,000 after buying an additional 605,583 shares during the last quarter. 7.30% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Ambev S.A. (ABEV) opened at 6.68 on Thursday. The stock has a market capitalization of $104.92 billion, a P/E ratio of 27.95 and a beta of 0.66. The firm’s 50-day moving average is $6.48 and its 200 day moving average is $5.94. Ambev S.A. has a 12-month low of $4.70 and a 12-month high of $6.86.
Ambev (NYSE:ABEV) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.04 EPS for the quarter, hitting the consensus estimate of $0.04. Ambev had a return on equity of 23.24% and a net margin of 27.14%. The company had revenue of $3.20 billion during the quarter, compared to the consensus estimate of $3.33 billion. On average, equities research analysts forecast that Ambev S.A. will post $0.23 EPS for the current fiscal year.
ABEV has been the topic of a number of research analyst reports. Zacks Investment Research downgraded shares of Ambev from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Barclays PLC reissued a “hold” rating on shares of Ambev in a report on Sunday, July 30th. BidaskClub downgraded shares of Ambev from a “strong-buy” rating to a “buy” rating in a report on Thursday, September 28th. Finally, Credit Suisse Group raised shares of Ambev from a “neutral” rating to an “outperform” rating in a report on Tuesday, September 12th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $6.48.
Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company’s activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in Dominican Republic, Saint Vincent, Antigua, Dominica, Guatemala, El Salvador, Nicaragua and Cuba; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile, Ecuador, Peru and Colombia, and Canada, represented by Labatt’s operations, which comprises sales in Canada.
Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV).
Receive News & Stock Ratings for Ambev S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev S.A. and related stocks with our FREE daily email newsletter.